LGND Stock: Price, Earnings History and SEC Filings
Ligand Pharmaceuticals Incorporated (LGND) last traded at $322.75, up 1.71% on the latest session and up 3.3% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $-1.43 against an analyst estimate of $1.42, a miss of 200.7%.
$322.75 +1.71%
1 month+3.32%
52-week high$326.63
52-week low$175.89
Volume344,311
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
LGND earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $-1.43 | $1.42 | -200.70% |
| Jun 2026 | Aug 6, 2026 | $2.22 | $1.34 | +65.67% |
| Mar 2026 | May 7, 2026 | $-0.67 | $0.98 | -168.37% |
| Dec 2025 | Feb 26, 2026 | $2.12 | $0.63 | +236.51% |
LGND beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for LGND
SEC filing data is not available right now. You can search for LGND on SEC EDGAR.
LGND news
- Ligand Pharmaceuticals Sees Strong Royalty Growth Ahead of Investor Day, Oppenheimer SaysOct 30, 2026 · finance.yahoo.com
- Ligand Pharmaceuticals (LGND) Stock Price Ignores Q3 Earnings Losses And Royalty StrengthOct 30, 2026 · finance.yahoo.com
- Ligand (LGND) Q3 2026 Earnings Call TranscriptOct 30, 2026 · fool.com
- Ligand Pharmaceuticals Incorporated Q3 2026 Earnings Call SummaryOct 30, 2026 · app.moby.co
- What Ligand Pharmaceuticals (LGND) Said on Its Q3 Earnings CallOct 29, 2026 · marketbeat.com
- Ligand: Q3 Earnings SnapshotOct 29, 2026 · finance.yahoo.com
- Ligand Reports Third Quarter 2026 Financial ResultsOct 29, 2026 · finance.yahoo.com
- Ligand to Participate in November Investor ConferencesOct 27, 2026 · finance.yahoo.com
About Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated (LGND) is a US-listed public company on Nasdaq.